Circulation
Overview
Circulation is a renowned peer-reviewed medical journal dedicated to cardiovascular research and clinical practice. It publishes cutting-edge studies, reviews, and guidelines, covering a wide range of topics including cardiology, vascular biology, and cardiovascular surgery. With its rigorous scientific approach, Circulation serves as a vital resource for healthcare professionals, researchers, and students seeking the latest advancements in cardiovascular medicine.
Details
Details
Abbr.
Circulation
Start
1950
End
Continuing
Frequency
Weekly (except the first two weeks in Jan. and the last two weeks in Dec.), <Apr. 8, 2003->
p-ISSN
0009-7322
e-ISSN
1524-4539
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 11
674
SJR / Ranks: 103
8415
CiteScore / Ranks: 87
42.10
JIF / Ranks: 52
37.8
Recent Articles
1.
Hull L, Aday A, Bui Q, Luzum J, Muchira J, Wand H, et al.
Circulation
. 2025 Mar;
PMID: 40079117
Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular clinicians increasingly face questions about its utility and interpretation because individuals can purchase these tests directly from...
2.
Guan Y, Liu X, Yang Z, Zhu X, Liu M, Du M, et al.
Circulation
. 2025 Mar;
PMID: 40071387
Background: Low-density lipoprotein (LDL) is internalized into cells mainly through LDLR (LDL receptor)-mediated endocytosis. In an acidic endosome, LDLR is released from LDL and recycles back to the cell surface,...
3.
Filipp M, Ge Z, DeBerge M, Lantz C, Glinton K, Gao P, et al.
Circulation
. 2025 Mar;
PMID: 40071347
Background: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment options remain limited. The HFpEF syndrome is associated with a high comorbidity burden, including...
4.
Michel L, Esfahani H, De Mulder D, Verdoy R, Ambroise J, Roelants V, et al.
Circulation
. 2025 Mar;
PMID: 40071326
Background: Cardiac β3-adrenergic receptors (ARs) are upregulated in diseased hearts and mediate antithetic effects to those of β1AR and β2AR. β3AR agonists were recently shown to protect against myocardial remodeling...
5.
6.
Kim E, Arya S, Bryce Y, Gornik H, Long C, McDermott M, et al.
Circulation
. 2025 Mar;
PMID: 40066579
Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been well described; however, the bulk of the literature has focused on heart disease...
7.
Papatheodorou E, Aengevaeren V, Eijsvogels T, AlFakih K, Kathryn Hughes R, Merghani A, et al.
Circulation
. 2025 Mar;
151(10):e709.
PMID: 40063726
No abstract available.
8.
Ambrosy A, Bensimhon D, Bernstein G, Kolski B, Neutel J, Lala A, et al.
Circulation
. 2025 Mar;
151(10):e708.
PMID: 40063725
No abstract available.
9.
10.
Claudel S, Verma A
Circulation
. 2025 Mar;
151(10):716-732.
PMID: 40063723
Albuminuria-increased urine albumin excretion-is associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Many...